A functional role for endogenous atrial natriuretic peptide in the maintenance of body fluid balance in heart failure.
Kinoshita
M
M
The First Department of Internal Medicine, Shiga University of Medical Science, Seta, Ohtsu.
Wada
A
A
D057911:Angiotensin Receptor Antagonists; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000502:physiology*; D001562:Benzimidazoles / Q000494:pharmacology; D001713:Biphenyl Compounds / Q000494:pharmacology; D006152:Cyclic GMP / Q000096:biosynthesis; D004195:Disease Models, Animal; D004285:Dogs; D065128:Endothelin Receptor Antagonists; D016232:Endothelins / Q000502:physiology; D006333:Heart Failure / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control; D011134:Polysaccharides / Q000494:pharmacology; D017461:Receptors, Atrial Natriuretic Factor / Q000037:antagonists & inhibitors; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology; D013777:Tetrazoles; D014882:Water-Electrolyte Balance / Q000502:physiology*
D057911:Angiotensin Receptor Antagonists; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D065128:Endothelin Receptor Antagonists; D016232:Endothelins; C072551:HS 142-1; D011134:Polysaccharides; D013777:Tetrazoles; D009320:Atrial Natriuretic Factor; D017461:Receptors, Atrial Natriuretic Factor; D006152:Cyclic GMP; C077793:candesartan cilexetil